 | Up a level |
Schleimann, Mariane H., Kobbero, Maria-Louise, Vibholm, Line K., Kjaer, Kathrine 
ORCID: 0000-0002-2367-2470, Giron, Leila B., Busman-Sahay, Kathleen, Chan, Chi Ngai, Nekorchuk, Michael, Schmidt, Manuel, Wittig, Burghardt, Damsgaard, Tine E., Ahlburg, Peter, Hellfritzsch, Michel B., Zuwala, Kaja, Rothemejer, Frederik H., Olesen, Rikke ORCID: 0000-0002-5157-080X, Schommers, Phillipp, Klein, Florian, Dweep, Harsh, Kossenkov, Andrew, Nyengaard, Jens R., Estes, Jacob D., Abdel-Mohsen, Mohamed, Ostergaard, Lars ORCID: 0000-0002-7619-605X, Tolstrup, Martin ORCID: 0000-0001-7020-5173, Sogaard, Ole S. and Denton, Paul W.
(2019).
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.
EBioMedicine, 45.
S. 328 - 341.
AMSTERDAM:
ELSEVIER.
ISSN 2352-3964
Weihrauch, Martin R., Richly, Heike, von Bergwelt-Baildon, Michael S., Becker, Hans Jiro, Schmidt, Manuel, Hacker, Ulrich T., Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Holtick, Udo, Nokay, Bahar, Schroff, Matthias, Wittig, Burghardt and Scheulen, Max E.
(2015).
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours.
Eur. J. Cancer, 51 (2).
S. 146 - 157.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852